These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 991109)

  • 21. Cytotoxicity responses to melanoma cells by human lymphoid cell subpopulations.
    O'Neill PA; Mackler BF; Romsdahl MM
    J Natl Cancer Inst; 1976 Aug; 57(2):431-4. PubMed ID: 1087348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen.
    Currie GA; Basham C
    Br J Cancer; 1972 Dec; 26(6):427-38. PubMed ID: 4119105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour-associated lymphocyte cytotoxicity superimposed on "spontaneous" cytotoxicity in melanoma patients.
    de Vries JE; Rümke P
    Int J Cancer; 1976 Feb; 17(2):182-90. PubMed ID: 942943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential in vitro reactivity of lymphocytes from melanoma patients receiving immunotherapy compared with the reactivity of lymphocytes from healthy donors.
    Berkelhammer J; Mastrangelo MJ; Laucius JF; Bodurtha AJ; Prehn RT
    Int J Cancer; 1975 Oct; 16(4):571-8. PubMed ID: 51835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactivity of human lymphocytes against autochthonous and allogeneic normal and tumor cells in vitro.
    Chu EH; Stjernswärd J; Clifford P; Klein G
    J Natl Cancer Inst; 1967 Oct; 39(4):595-617. PubMed ID: 18623923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absorption of blocking activity from human tumor-bearer sera by Staphylococcus aureus, Cowan I.
    Steele G; Ankerst J; Sjögren HO; Vang J; Lannerstad O
    Int J Cancer; 1975 Feb; 15(2):180-9. PubMed ID: 1126756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variables and specificity of in vitro lymphocyte-mediated cytotoxicity in human melanoma.
    Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
    Cancer Res; 1975 Dec; 35(12):3721-30. PubMed ID: 1192430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.
    Hellström I; Sjögren HO; Warner G; Hellström KE
    Int J Cancer; 1971 Mar; 7(2):226-37. PubMed ID: 5104167
    [No Abstract]   [Full Text] [Related]  

  • 29. Human sarcomas in culture. Foci of altered cells and a common antigen; induction of foci and antigen in human fibroblast cultures by filtrates.
    Giraldo G; Beth E; Hirshaut Y; Aoki T; Old LJ; Boyse EA; Chopra HC
    J Exp Med; 1971 Mar; 133(3):454-78. PubMed ID: 4329447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificity of cellular immunity to renal cell carcinoma.
    Daly JJ; Prout GR; Ahl CA; Lin JC
    J Urol; 1974 Apr; 111(4):448-52. PubMed ID: 4819368
    [No Abstract]   [Full Text] [Related]  

  • 31. Cellular and humoral immunity to different types of human neoplasms.
    Hellström I; Hellström KE; Pierce GE; Yang JP
    Nature; 1968 Dec; 220(5174):1352-4. PubMed ID: 4302696
    [No Abstract]   [Full Text] [Related]  

  • 32. Specificity of antitumor immune reactions mediated by xenogeneic immune RNA.
    Kern DH; Drogemuller CR; Chow N; Holleman DD; Pilch YH
    J Natl Cancer Inst; 1977 Jan; 58(1):117-21. PubMed ID: 833854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
    Bloom ET
    Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
    [No Abstract]   [Full Text] [Related]  

  • 34. Cell-mediated immunity and blocking factors in patients with tumours of the central nervous system.
    Kumar S; Taylor G; Steward JK; Waghe MA; Morris-Jones P
    Int J Cancer; 1973 Jul; 12(1):194-205. PubMed ID: 4364270
    [No Abstract]   [Full Text] [Related]  

  • 35. Tumor immunity and the mechanism of polyinosinic-polycytidylic acid inhibition of tumor growth.
    Kreider JW; Benjamin SA
    J Natl Cancer Inst; 1972 Nov; 49(5):1303-10. PubMed ID: 4568087
    [No Abstract]   [Full Text] [Related]  

  • 36. Alteration of in vitro anti-tumor activity of tumor-bearer sera by absorption with Staphylococcus aureus, Cowan I.
    Steele G; Ankerst J; Sjögren HO
    Int J Cancer; 1974 Jul; 14(1):83-92. PubMed ID: 4376510
    [No Abstract]   [Full Text] [Related]  

  • 37. Lymphocyte-mediated immune responses in neoplasia.
    Pilch YH; Golub SH
    Am J Clin Pathol; 1974 Aug; 62(2):184-211. PubMed ID: 4602086
    [No Abstract]   [Full Text] [Related]  

  • 38. Spontaneous and antibody-dependent cellular cytotoxicity in melanoma patients and healthy control presons.
    Peter HH; Knoop F; Kalden JR
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):263-81. PubMed ID: 134545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity.
    Hellström I; Hellström KE; Sjögren HO; Warner GA
    Int J Cancer; 1971 Sep; 8(2):185-91. PubMed ID: 4332366
    [No Abstract]   [Full Text] [Related]  

  • 40. Specific anti-fibroblast cytotoxicity of antibodies to fibroblast surface antigen.
    Ruoslahti E; Sjögren HO
    Int J Cancer; 1976 Sep; 18(3):375-8. PubMed ID: 60290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.